Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steel Perlot is a private deep-tech management company, investor, and incubator headquartered in New York. The firm builds and backs platform technology companies across sectors including artificial intelligence, semiconductors, finance, energy, and synthetic biology. It appears to operate more as a venture creation and investment organization than as a dedicated biotech, pharma, or healthcare operating company. Publicly available information does not indicate that Steel Perlot itself has a therapeutic pipeline, clinical programs, or commercial healthcare products. In the life sciences context, its relevance is limited to broader deep-tech and synthetic biology exposure rather than direct drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Steel Perlot.